As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide and semaglutide are the only two GLP-1 drugs FDA-approved to treat obesity in kids ages 12 and up.

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard about medications like Ozempic® that can help manage blood sugar levels and weight.

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an endocrinologist at Northwell Lenox Hill Hospital, told The Post.

The U.S. Food and Drug Administration has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents

Dr. Danish Ali discusses the dangers associated with alternate versions of a popular weight loss drug. Deion Sanders imposed harsh punishment on Colorado players after they disregarded his game plan A Man Went on a Hike—and Found a Mysterious Cart Buried Under Ice for Decades US Navy destroyers unscathed after fighting off a complex attack of cruise and ballistic missiles and exploding drones How ‘Yellowstone’ Honored a Cowboy Legend Trump taps Elon Musk and Vivek Ramaswamy to lead Department of Government Efficiency The Brands Behind 19 Popular Kirkland Products At Costco The unhealthiest fast-food sandwich in America isn't a Big Mac,